IRISanRaf

STOCCHI, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.954
AS - Asia 1.884
EU - Europa 401
Continente sconosciuto - Info sul continente non disponibili 109
OC - Oceania 8
SA - Sud America 5
AF - Africa 1
Totale 7.362
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.204
TR - Turchia 1.722
CA - Canada 750
IT - Italia 134
CN - Cina 113
EU - Europa 109
IE - Irlanda 73
DE - Germania 63
UA - Ucraina 42
IN - India 22
FR - Francia 18
GB - Regno Unito 17
FI - Finlandia 14
JP - Giappone 12
RO - Romania 8
GR - Grecia 7
NL - Olanda 6
AU - Australia 5
KR - Corea 5
SE - Svezia 5
IL - Israele 4
BR - Brasile 3
CH - Svizzera 3
ES - Italia 3
NZ - Nuova Zelanda 3
DK - Danimarca 2
PL - Polonia 2
SG - Singapore 2
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
CO - Colombia 1
EG - Egitto 1
HK - Hong Kong 1
MK - Macedonia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
RU - Federazione Russa 1
Totale 7.362
Salva come PNG Salva come JPEG
Città #
Kocaeli 1.718
San Mateo 1.267
Toronto 743
Chandler 386
Houston 375
Wilmington 369
Lawrence 246
Princeton 246
Fairfield 148
Ashburn 136
Beijing 101
Woodbridge 86
Seattle 75
Los Angeles 69
Cambridge 33
Dublin 27
Boardman 15
Helsinki 14
Rome 11
Redwood City 9
West Jordan 8
Andover 7
Brooklyn 7
Redmond 7
Solagna 7
Boston 6
Frankfurt am Main 6
Kyiv 6
Pune 6
Timisoara 6
Washington 6
Florence 5
Rockville 5
Milan 4
Minoh 4
Nocera Inferiore 4
Seoul 4
Shanghai 4
Aparecida de Goiania 3
Austin 3
Cisterna di Latina 3
Dallas 3
Genova 3
Giresun 3
Mumbai 3
Napoli 3
Norwalk 3
Santa Clara 3
Southwark 3
Sydney 3
Auburn 2
Auckland 2
Bologna 2
Borås 2
Certaldo 2
Chengdu 2
Chennai 2
Chioggia 2
Des Moines 2
Kempten (Allgaeu) 2
Larissa 2
London 2
Melbourne 2
Nagoya 2
Naples 2
Nea Michaniona 2
Ottawa 2
Raanana 2
Tokyo 2
Acerra 1
Allentown 1
Ann Arbor 1
Aprilia 1
Arco 1
Birmingham 1
Bogotá 1
Brighton 1
Casaleone 1
Castelnuovo Bormida 1
Catanzaro 1
Chestertown 1
Clearwater 1
Cork 1
Dagenham 1
Dearborn 1
Depoe Bay 1
Eden Prairie 1
Esentepe 1
Finale Ligure 1
Giulianova 1
Granada 1
Greenwich 1
Guangzhou 1
Hamburg 1
Hamilton 1
Hefei 1
Induno Olona 1
Jenera 1
Jerusalem 1
Jinan 1
Totale 6.281
Salva come PNG Salva come JPEG
Nome #
Morbo di Parkinson: strategie terapeutiche e qualità della vita del malato 85
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 74
L’alimentazione del paziente parkinsoniano 62
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on qualità of life in Parkinson’s disease 62
A pharmacological study of dopaminergic receptors in planaria 54
Apomorphine and lisuride infusion. A comparative chronic study 53
Modification of respiratory function parameters in patients with severe Parkinson's disease 48
Adherence to antiparkinson medication in a multicenter European study 48
Gastrointestinal dysfunction in Parkinson's disease 47
One year treatment with lisuride delivery pump in Parkinson's disease 47
Side-effects of subcutaneous apomorphine in Parkinson's disease 46
Neuroprotection in Parkinson's disease: clinical trials 44
Advances in Alzheimer's and Parkinson's Disease: Insights, Progress, and Perspectives 43
Robot-assisted gait training versus treadmill training in patients with Parkinson's disease: a kinematic evaluation with gait profile score Epub 2016 43
Managing the critical problems of advanced Parkinson's disease 43
Acute Modulation of Brain Connectivity in Parkinson Disease after Automatic Mechanical Peripheral Stimulation: A Pilot Study 42
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 42
Case Study 10 41
Clinical efficacy of a single afternoon dose of effervescent levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson disease 41
Clinical Experiences With Levodopa Methylester (Melevodopa) in Patients With Parkinson Disease Experiencing Motor Fluctuations: An Open-Label Observational Study 41
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease 41
Antagonist effect of terguride in Parkinson's disease 40
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia 40
Corneal and blink reflexes in Parkinson's disease with "on-off" fluctuations 39
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor 39
The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson disease 39
A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm 39
White matter disease (Binswanger's encephalopathy) in chronic cerebrovascular disorders 39
Unusual cardiovascular response to intravenous lisuride bolus. Possible drug-induced coronary angiospasm 39
Management of gastrointestinal alterations in Parkinson's disease 38
Transient left bundle branch block following intravenous lisuride bolus 38
Levodopa: A new look at an old friend 38
Continuous dopamine-receptor stimulation in advanced Parkinson's disease 38
Jejunal delivery of levodopa methyl ester 37
Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson's disease 37
A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients 37
Constipation in Parkinson's Disease 37
The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's disease 37
On-off phenomena in Parkinson's disease. Continuous dopaminergic stimulation 37
Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results 37
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 37
Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies 36
Malattie Extrapiramidali: aspetti clinici e terapeutici nelle sindromi parkinsoniane 36
Combination of two different dopamine agonists in the management of Parkinson's disease 36
Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease 36
Comparison between L-dopa and lisuride intravenous infusions: a clinical study 36
GIGYF2 mutations are not frequent cause of familiar Parkinson’s disease 36
Analyzing gait variability and dual-task interference in patients with Parkinson's disease and freezing by means of the word-color Stroop test 36
Repeated levodopa infusions in fluctuating Parkinson's disease: clinical and pharmacokinetic data 36
The coefficient of friction in Parkinson's disease gait 36
Parkinson's Disease: Non-motor and non-dopaminergic Features 35
Transient cardiac arrest during continuous intravenous infusion of apomorphine 35
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics 35
The Bereitschaftspotential preceding simple foot movement and initiation of gait in Parkinson's disease 35
Prevention and treatment of motor fluctuations 35
Motor fluctuations in levodopa treatment: clinical pharmacology 35
Use of Apomorphine in Parkinson’s Disease 35
Optimising levodopa therapy for the management of Parkinson's disease 35
Gastrointestinal, urological, and sleep problems in parkinson's disease 34
Emergencies in Parkinson's disease 34
Multicenter trial of L-Deprenyl in Parkinson disease 34
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations 34
Effects of terguride in patients with Huntington's disease 34
An appraisal of the problem of dementia in Parkinson's disease 34
Clinical implications of sustained dopaminergic stimulation. 34
Wearing-off scales in Parkinson's disease: Critique and recommendations 34
trategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias 34
Novel parkin mutations detected in patients with early-onset Parkinson's disease 34
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients 34
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism 34
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment 34
Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder 34
Transient atrial fibrillation after subcutaneous apomorphine bolus 34
A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need 34
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 34
Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease 33
Instrumental diagnosis of multiple system atrophy 33
Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease: a clinical and pharmacokinetic study 33
The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson’s disease 33
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease 33
Determination of apomorphine in human plasma by alumina extraction and high-performance liquid chromatography with electrochemical detection 33
Alterations of thermoregulation in Parkinson's disease 33
Farmaci Antiparkinsoniani 33
The vatican meeting on neuroprotection for Parkinson's disease 32
Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms 32
Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease 32
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease 32
Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease 32
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial 32
Dual dopamine agonist treatment in Parkinson's disease 32
Benefits of treatment with rasagiline for fatigue symptoms in patients with early Parkinson's disease 32
The effect of steady-state ropinirole on plasma concentrations of digoxin in patients with Parkinson's disease 32
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease 32
Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease 32
A double-blind, delayed-start trial of rasagiline in Parkinson’s disease 32
Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPA 31
Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms 31
Obstacles to the development of a neuroprotective therapy for Parkinson's disease 31
The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease 31
Effectiveness of risk minimization measures for cabergoline-induced cardiac valve fibrosis in clinical practice in Italy 31
Totale 3.794
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.997
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 0 4
2019/2020501 14 42 9 4 122 14 16 3 15 55 74 133
2020/20212.647 144 132 35 8 44 168 82 39 62 47 1.721 165
2021/20222.453 11 752 749 9 6 1 204 277 17 347 6 74
2022/20231.281 554 35 12 116 82 31 0 83 93 111 160 4
2023/2024612 4 19 81 241 50 44 15 59 12 87 0 0
Totale 7.751